Why Rapid Micro Biosystems, Inc.’s (RPID) Stock Is Down 6.33%
As of Thursday, July 16, Rapid Micro Biosystems, Inc.’s RPID share price has dipped by 6.33%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Stock Evaluator: Rapid Micro Biosystems, Inc. (RPID)
Rapid Micro Biosystems, Inc. RPID
$2.13
0.02
0.95%
July 31, 2026 4:00:00 PM
EST
Volume: 20,557
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Life Sciences Tools & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Commentary & Analysis
Why Rapid Micro Biosystems, Inc.’s (RPID) Stock Is Up 6.93%
As of Wednesday, June 17, Rapid Micro Biosystems, Inc.’s RPID share price has surged by 6.93%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Rapid Micro Biosystems, Inc.’s (RPID) Stock Is Up 6.06%
As of Wednesday, May 20, Rapid Micro Biosystems, Inc.’s RPID share price has surged by 6.06%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why Rapid Micro Biosystems, Inc.’s (RPID) Stock Is Down 5.80%
As of Monday, May 18, Rapid Micro Biosystems, Inc.’s RPID share price has dipped by 5.80%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Rapid Micro Biosystems, Inc.’s (RPID) Stock Is Down 8.62%
As of Friday, May 15, Rapid Micro Biosystems, Inc.’s RPID share price has dipped by 8.62%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Financial Summary
| Share Statistics | RPID | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $103.8 | $1,774.7 | 22% |
|
| Shares Out (Mil) | 45.4 | 94.8 | 45% |
|
| Institutional Ownership | 87.3% | 90.1% | 55% |
|
| Float (Mil) | 32.2 | 69.9 | 38% |
|
| Beta | 1.47 | 1.20 | 82% |
|
| Avg Daily Volume (000s) | 176 | 838 | 43% |
|
| Price Change (52-week) |
(43.9%) | 81.0% | 18% |
|
| Growth | RPID | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 15.9% | 7.8% | 74% |
|
| Net Income (5yr) | (4.9%) | (13.7%) | 34% |
|
| EPS (5yr) | 61.6% | 0.7% | 96 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (73.0%) | (15.0%) | 2% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 3 | 3 | |
| Current EPS | ($0.243) | ($0.930) | ($0.790) | |
| Month Ago EPS | ($0.243) | ($0.930) | ($0.790) | |
| # Rev Up | 1 | 1 | 0 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | ($0.233) | ($0.923) | ($0.823) | |
| Year/Year Chg | (22.6%) | (11.8%) | (55.5%) | |
| Financials | RPID | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $34 | $763 | 17% |
|
| Net Income (TTM) (Mil) | ($50) | ($14) | 16% |
|
| EPS (TTM) | ($1.113) | ($0.200) | 20% |
|
| Operating Cash Flow (TTM) (Mil) | ($37) | $53 | 11% |
|
| Net Cash Flow (TTM) (Mil) | ($5) | ($5) | 34% |
|
| Long-Term Debt (Q1) (Mil) | $22 | $270 | 34% |
|
| Enterprise Value (Q1) (Mil) | $102 | $2,430 | 21% |
|
| Valuation | RPID | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.67 | 3.00 | 77% |
|
| P/E | na | 43.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 5.3 | na |
|
| Ratios | RPID | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 2.9% | 47.6% | 5% |
|
| Net Margin | (145.8%) | (2.9%) | 6% |
|
| ROA | (67.8%) | (3.2%) | 9% |
|
| ROE | (116.7%) | (4.5%) | 8% |
|
| Liabilities to Assets | 67.3% | 43.0% | 63% |
|
| F-Score | 2 | 5 | 7% |
|
Rapid Micro Biosystems, Inc. did not pass any screens on 7/30/2026.
